Orphan designation: Reldesemtiv Treatment of amyotrophic lateral sclerosis, 28/02/2020 Positive | European Federation of Internal Medicine

Submitted by Anonymous (not verified) on 11 October 2024 - 10:00

Orphan designation: Reldesemtiv Treatment of amyotrophic lateral sclerosis, 28/02/2020 Positive

Link:

https://www.ema.europa.eu/en/medicines/human/orphan-designations/eu-3-20-2256

Source:

Newsletters

Stay informed on our latest news!

Latest Newsletters